July 29, 2026 · earnings
TEVA earnings: a positive outcome, +9.6%
On July 29, 2026, Teva Pharmaceutical Industries Limited reached its earnings. The result was a positive outcome, and the stock moved +9.6% in the window around the event. It had already run -7.5% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.
The move
$31.67
1d before
$34.71
Event day
$35.41
1d after
$34.46
5d after
Our prediction vs. the result
CatalystAlert called this one neutral (+3.5% expected); the stock actually moved +9.6%. Model confidence at the time: 78%.
See the full scored track recordPre-catalyst setup
-7.5%
30-day run-up
3478%
30-day volatility
1.0×
volume spike
